Literature DB >> 28605192

Absolute Protein Quantification by Mass Spectrometry: Not as Simple as Advertised.

Christopher M Shuford1, James J Walters2, Patricia M Holland1, Uma Sreenivasan3, Nadav Askari4, Kevin Ray2, Russell P Grant1.   

Abstract

Stable isotopically labeled (SIL) tryptic peptides, cleavable SIL peptides, and a full-length SIL protein were compared for internal calibration (i.e., as internal calibrators) and external calibration (i.e., as internal standards) when quantifying three forms of unlabeled, human thyroglobulin (Tg) by bottom-up protein analysis. All SIL materials and human proteins were standardized by amino acid analysis to ensure traceability of measurements and allow confident assignment of accuracy. The three forms of human Tg quantified were (1) the primary reference material BCR457-a native protein purified from human thyroids, (2) a commercially available form also purified from human thyroids, and (3) a full-length recombinant form expressed and purified from a human embryonic kidney 293 cell-line. Collectively, the results unequivocally demonstrate the lack of commutability of tryptic and cleavable SIL peptides as internal calibrators across various bottom-up assays (i.e., denaturing/digestion conditions). Further, the results demonstrate the potential during external calibration for surrogate protein calibrators (i.e., recombinant proteins) to produce inaccurate concentration assignments of native protein analytes by bottom-up analysis due to variance in digestion efficiency, which is not alleviated by altering denaturation/digestion stringency and indicates why protein calibrators may not be commutable in bottom-up protein assays. These results have implications regarding the veracity of "absolute" protein concentration assignments by bottom-up assays using peptide calibrators, as well as protein calibrators, given that absolute accuracy was not universally observed. Nevertheless, these results support the use of recombinant SIL proteins as internal standards over SIL peptides due to their ability to better mimic the digestion of human-derived proteins and mitigate bias due to digestion-based matrix effects that were observed during external calibration.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28605192     DOI: 10.1021/acs.analchem.7b00858

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  17 in total

1.  Pharmacokinetic Analysis of a Novel Human EGFRvIII:CD3 Bispecific Antibody in Plasma and Whole Blood Using a High-Resolution Targeted Mass Spectrometry Approach.

Authors:  Teilo H Schaller; Matthew W Foster; J Will Thompson; Ivan Spasojevic; Deimante Normantaite; M Arthur Moseley; Luis Sanchez-Perez; John H Sampson
Journal:  J Proteome Res       Date:  2019-07-19       Impact factor: 4.466

2.  Simultaneous LC/MS/MS quantification of eight apolipoproteins in normal and hypercholesterolemic mouse plasma.

Authors:  Richard Wagner; Julia Dittrich; Joachim Thiery; Uta Ceglarek; Ralph Burkhardt
Journal:  J Lipid Res       Date:  2019-02-05       Impact factor: 5.922

3.  Quantitative non-targeted analysis: Bridging the gap between contaminant discovery and risk characterization.

Authors:  James P McCord; Louis C Groff; Jon R Sobus
Journal:  Environ Int       Date:  2021-12-02       Impact factor: 9.621

Review 4.  Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses.

Authors:  L Renee Ruhaak; Gege Xu; Qiongyu Li; Elisha Goonatilleke; Carlito B Lebrilla
Journal:  Chem Rev       Date:  2018-03-19       Impact factor: 60.622

Review 5.  Clinical potential of mass spectrometry-based proteogenomics.

Authors:  Bing Zhang; Jeffrey R Whiteaker; Andrew N Hoofnagle; Geoffrey S Baird; Karin D Rodland; Amanda G Paulovich
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

6.  Calibration Using a Single-Point External Reference Material Harmonizes Quantitative Mass Spectrometry Proteomics Data between Platforms and Laboratories.

Authors:  Lindsay K Pino; Brian C Searle; Eric L Huang; William Stafford Noble; Andrew N Hoofnagle; Michael J MacCoss
Journal:  Anal Chem       Date:  2018-10-23       Impact factor: 6.986

7.  Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a).

Authors:  Santica M Marcovina; Noémie Clouet-Foraison; Marlys L Koschinsky; Mark S Lowenthal; Allen Orquillas; Michael B Boffa; Andrew N Hoofnagle; Tomáš Vaisar
Journal:  Clin Chem       Date:  2021-03-01       Impact factor: 12.167

8.  Effects of alcohol-induced increase in CYP2E1 content in human liver microsomes on the activity and cooperativity of CYP3A4.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Marc A Maldonado; Armina Abbasi; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Arch Biochem Biophys       Date:  2020-11-13       Impact factor: 4.013

Review 9.  The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.

Authors:  Henry Rodriguez; Jean Claude Zenklusen; Louis M Staudt; James H Doroshow; Douglas R Lowy
Journal:  Cell       Date:  2021-04-01       Impact factor: 41.582

10.  HILIC-MRM-MS for Linkage-Specific Separation of Sialylated Glycopeptides to Quantify Prostate-Specific Antigen Proteoforms.

Authors:  Yuri E M van der Burgt; Kasper M Siliakus; Christa M Cobbaert; L Renee Ruhaak
Journal:  J Proteome Res       Date:  2020-03-18       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.